Oral Presentations

Oral Presentations

Day 1

1A1 Gall Bladder Cancers in India: A Report From Population-Based Cancer Registries (1982-2010) M Chaturvedi, Indian Council of Medical Research, Bangalore, India

1A2 Early Age of Onset in 200 Lymphoid Cancer Families S Jones, BC Cancer Research Centre, Vancouver, BC, Canada

1A3 Time Trend and Incidence Pattern of Breast Cancer at the Ibadan Cancer Registry, Nigeria over a Twenty Year Period: 1998-2017 G Ogun, University of Ibadan, Ibadan, OY, Nigeria

1B1 Comparative Net Survival of Elderly Patients with Cancer: Data from the Cancer Registry of Guadeloupe F.W.I. J Deloumeaux, Cancer Registry of Guadeloupe, University Hospital of Guadeloupe, Pointe-à- Pitre, Guadeloupe, GA, France

1B3 Colorectal Cancer Survival Disparities in California 1997-2014 D Oh, University of California, San Francisco, CA, United States

1B4 The Burden of Cancer in Nova Scotia: An Evaluation of Loss in Expectation of Life R Dewar, Nova Scotia Health Authority – Cancer Care Program, Halifax, NS, Canada

1B5 Trends in Survival from Metastatic Lung Cancer in California, 1990-2014 R Cress, Cancer Registry of Greater California, Sacramento, CA, United States

1D1 Pertinence of the WHO 2010 Guideline on NEC Diagnosis JM van der Zwan, Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, Netherlands

1D2 Dual Primary Malignancies: A Cause of Concern S Jaitley, Rajiv Gandhi Cancer Institute & Research Center, New Delhi, India

1D3 Developing a REDCap Inquiry System to Facilitate Case Specific Communication between Hospital Registrars and Central Registry Operations Editing Staff C Bateman, Utah Cancer Registry, Salt Lake City, UT, United States

1D4 Louisiana’s Hospital Follow-up Exchange: A Decade of Partnership C Lefante, Louisiana Tumor Registry, New Orleans, LA, United States

1E1 Assessment of Breast and Colorectal Cancer Surgery in Manitoba I Ratnayake, CancerCare Manitoba, Winnipeg, MB, Canada

1E2 Methodology of Conducting the Pattern of Ovarian Cancer Care and Survival in the Midwestern Region of the United States W Ross, Westat Inc., Rockville, MD, United States

1E3 Treatment of Stage IV Colon Cancer in the U.S.: A Pattern of Care Analysis X Gao, State Health Registry of Iowa, Iowa City, IA, United States

1E4 Urban-Rural Variations in Quality of Care and Survival among Cancer Patients in California A Parikh-Patel, California Cancer Reporting and Epidemiologic Surveillance Program, Institute for Population Health Improvement, UC Davis Health, Sacramento, CA, United States

1F1 Elevating the Science of Cancer Research by Using the Central Cancer Registry as a Virtual Tissue Repository (VTR) T Tucker, Kentucky Cancer Registry, Lexington, KY, United States

1F2 Using Cancer Registry Infrastructure and Linkage to Biobank Facilities to Investigate the Role of Infectious Agents in the Progression from Oesophageal Premalignancy to Cancer L Anderson, Northern Ireland Cancer Registry, Belfast, United Kingdom

1F3 SEER-Linked Virtual Tissue Repository (VTR) and Preliminary Pilot Program Findings: Lessons Learned about Tissue and Future Visione A Van Dyke, National Cancer Institute, Bethesda, MD, United States

1G1 Implementing a Sub-Regional Virtual Cancer Registry to Support Cancer Registration in 10 Caribbean Countries S Quesnel-Crooks, IARC Caribbean Cancer Registry Hub, Port of Spain, Trinidad and Tobago

1G2 IARC Regional Hub for Cancer Registration, Mumbai, India L Mery, International Agency for Research on Cancer, Lyon, France

1G3 Overcoming Challenges Related to Cancer Case Identification in Rural West Guyana S Quesnel-Crooks, IARC Caribbean Cancer Registry Hub, Port of Spain, Trinidad and Tobago

1H1 NAACCR Geocoder Micro Match Status Codes: Criteria for Assessing Geographic Microdata Fitness for Use in High Resolution Spatial Analysis D Goldberg, Texas A&M University, College Station, TX, United States

1H2 Evaluation of Geocoding Quality in Montana: Considerations for Sub-County Analysis H Zimmerman, Montana Central Tumor Registry, Helena, MT, United States

1H3 Comparison of Two Geocoding Approaches to Estimate the Effect of Residential Ambient Pesticide Exposure on Prostate Cancer L Thompson, University of Colorado, Denver, CO, United States

1H4 NAACCR Geocoder Alias Tables: Improving Geocoding Quality Through the Inclusion of Placename Aliases D Goldberg, Texas A&M University, College Station, TX, United States

2A1 Geographical and Temporal Differences in Gastric and Oesophageal Cancer in Europe F Giusti, European Commission – DG Joint Research Centre, Brussels, Belgium

2A2 Demographic and Epidemiological Transition and Cancer in India A Mathew, Regional Cancer Centre, Trivandrum, Kerala, India

2A3 Changing Trends in Thyroid Cancer Incidence in Canada: A Histologic Examination, 1992 to 2016 L Ellison, Canadian Cancer Registry, Health Statistics Division, Statistics Canada,
Ottawa, ON, Canada

2A4 Incidence and Mortality of Childhood Cancer in China from 2000 to 2015 K Sun, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

2D1 Implementation of ePath Reporting in California: Setting Data Quality Standards A Sipin-Baliwas, Los Angeles Cancer Surveillance Program -USC, Los Angeles, CA, United States

2D2 Implementation of ePath Reporting in California: Challenges for Small and MediumSized Facilities D Deapen, Los Angeles Cancer Surveillance Program -USC, Los Angeles, CA, United States

2D3 Outpatient Clinic Reporting: Understanding the Landscape and Establishing Reporting Processes A Sipin-Baliwas, Los Angeles Cancer Surveillance Program -USC, Los Angeles, CA, United States

2E1 The Impact of Novel Agents on Multiple Myeloma: Trends of Incidence and Mortality in Japan Y Usui, Aichi Cancer Center Hospital, Nagoya, Japan

2E2 Measuring the Implementation of Recommendations on Patient Centred Management of Localized Prostate Cancer with Population Based Cancer Registration Data L Van Eycken, Belgian Cancer Registry, Brussels, Belgium

2E3 Methods, Results, and Lessons Learned from Two Postmarketing Drug Safety Surveillance Studies Linking State Cancer Registry Data to Large Pharmacy Databases D Harris, RTI Health Solutions, Research Triangle Park, NC, United States

2E3 Methods, Results, and Lessons Learned from Two Postmarketing Drug Safety Surveillance Studies Linking State Cancer Registry Data to Large Pharmacy Databases D Harris, RTI Health Solutions, Research Triangle Park, NC, United States

2E4 Developing an Integrated Clinical Decision-Making Scheme (ICDS) for Predicting SPCs in Women with Endometrial Cancer: A Retrospective Analysis in Taiwan and Thailand C Chang, Chung-Shan Medical University, Taichung, Taiwan

2F1 Cancer Registration in the Era of Genomics: Integrating Germline and Somatic Genetic Data into the Cancer Registration System for England F McRonald, Public Health England, Birmingham, United Kingdom

2F2 Linked OncotypeDX DCIS Test in SEER: Quality Assessment and Clinical Significance Y Yuan, National Cancer Institute, Bethesda, MD, United States

2F3 Multigene Genomic Testing (Oncotype DX) Among New York (NY) Prostate Cancer Patients, 2015-2016 J Harrison, New York State Cancer Registry, Menands, NY, United States

2F4 Enhancing Cancer Surveillance: Statewide Collection of Biomarkers and Prognostic Factors, Colorado’s Multi-Phase Implementation K Vu, Colorado Central Cancer Registry, Denver, CO, United States

2G1 Changes in Health-Related Quality of Life in Older Women after Diagnosis with Gynecologic Cancer A Klapheke, Cancer Registry of Greater California, Sacramento, CA, United States

2G2 Influence of Depression on Treatment and Survival: A Population-Based Study for Breast Cancer Patients in Kentucky B Huang, Kentucky Cancer Registry, Lexington, KY, United States

2G3 Impact of Depression and Comorbidity on Suicide for Cancer Patients T Huang, Tulane University, New Orleans, KY, United States

2G4 Impact of Navigation and Neighborhoods on Breast Cancer Survivorship D Oh, University of California, San Francisco, CA, United States

2G5 Do Latinas with Breast Cancer who Live in Ethnic Enclaves have Better or Worse Survival? Analysis of Cancer Registry Data from California and Texas S Shariff-Marco, Greater Bay Area Cancer Registry, San Francisco, CA, United States

2H1 Cancer Surveillance Data of Rare Epithelial Breast Cancers – A Report from Population-Based Cancer Registries in India S TS, NCDIR, ICMR, Bangalore, KS, Indiav

2H2 Breast Cancer Treatment According to Pathogenic Variants in Cancer Susceptibility Genes in a Population-Based Cohort S Katz, University of Michigan, Ann Arbor, MI, United States

2H3 Differences in Breast Cancer Survival by Molecular Subtypes in the United States N Howlader, National Cancer Institute, Bethesda, MD, United States

Day 2

3A1 Lung Cancer Incidence Rates in Young Women Versus Young Men: A Systematic Analysis in 40 Countries M Fidler-Benaoudia, Department of Cancer Epidemiology and Prevention Research, Cancer Control Alberta, Alberta Health Services, Calgary, AB, Canada

3A2 Global Trends in Colorectal Cancer Incidence Rates in Young Adults R Siegel, American Cancer Society, Atlanta, GA, United States

3A3 U.S. Cancer Statistics Public Use Database Annual Percent Change of ScreeningAmenable Cancers by State, United States, 2011-2015 R Wilson, Centers for Disease Control and Prevention, Atlanta, GA, United States

3A4 U.S. Cancer Statistics Public Use Database Annual Percent Change of ScreeningAmenable Cancers by State, United States, 2011-2015 R Wilson, Centers for Disease Control and Prevention, Atlanta, GA, United States

3A5 Lung Cancer Incidence in Young Blacks Versus Whites in the United States A Jemal, American Cancer Society, Atlanta, GA, United States

3B1 Assessing Population-Based Cancer Survival Trends by Using the North American Cancer Survival Index – United States, 2005-2014 B Morawski, Centers for Disease Control and Prevention, Boise, ID, United States

3B3 Disease Free Survival for Non-Metastatic Colorectal Cancer Cases in Three Referral Hospitals in Iran; Interim Report of the CRC Quality Registry Network (QRN-CRC) M Reza Rouhollahi, Cancer Research Institute, Iran

3B4 Education and Stage of Cancer at Diagnosis: A Population-Based Study in South India P George, Trivandrum, KL, India

3D1 The Progress of NPCR Audits – What We Have Done, What We Have Learned, and Where Are We Going Now M Lewis, Centers for Disease Control and Prevention, Atlanta, GA, United States

3D2 Early Case Capture of Pediatric and Young Adult Cancers: Considerations for Future Rapid Case Ascertainment Studies MA Lynch, Louisiana Tumor Registry, New Orleans, LA, United States

3D3 Improving Mortality Reporting to State Cancer Registries through National Vital Statistics System Modernization Efforts W Blumenthal, Centers for Disease Control and Prevention, Atlanta, GA, United States

3D5 Use of Hospital Discharge Data to Increase Reporting of Non-malignant Central Nervous System Tumors MJ King, Ontario Cancer Registry, Toronto, Ontario, Canada

3E1 VPR-CLS Pilot Testing and Next Steps C Clerkin, North American Association of Central Cancer Registries, Springfield, IL, United States

3E2 Web Portal for Virtual Pooled Registry Cancer Linkage System (VPR-CLS) Phase I and Phase II Functionality D Green, Information Management Services, Inc., Calverton, MD, United States

3E3 Status of the Templated IRB/Registration Application, Implementation of the Central IRB and Local Context Issues S Friedman, National Cancer Institute, Rockville, MD, United States

3E4 Cancer Ascertainment by U.S. Population-Based Cancer Registries, Self-Report and Death Certificates in the Nationwide U.S. Radiologic Technologists Cohort: A Preliminary Report D Liu, National Cancer Institute, Rockville, MD, United States

3F1 Essential TNM-Evaluation of a Training Exercise in Sub- Saharan Africa E Chokunonga, Zimbabwe National Cancer Registry, Avondale, Harare, Zimbabwe

3F2 Improvements in National Staging Ascertainment in England (2011-2016) M Eden, National Cancer Registration and Analysis Service, Public Health England, Cambridge, United Kingdom

3F3 Neoadjuvant Treatment Results: Only Part of the Story/The Missing Piece D Gress, American College of Surgeons, American Joint Committee on Cancer, Chicago, IL, United States

3F4 Population Based Cancer Registry Survival Data Argue for Subdivision of TNM Stage III Prostate Cancer and Merging CT2-Subcategories L Van Eycken, Belgian Cancer Registry, Brussels, Belgium

3G1 Rare Cancers are also not Rare in Asia: The Rare Cancer Burden in East Asia T Matsuda, National Cancer Registry Center & National Cancer Center, Japan

3G2 Primary Malignant Cardiac Tumors in California L Liu, Los Angeles Cancer Surveillance Program -USC, Los Angeles, CA, United States

3G3 Kaposi Sarcoma as Indicator Disease for HIV Prevalence in the Netherlands: A Population-Based Study V Ho, IKNL, Utrecht, Netherlands

3H1 A New Statistical Method for Estimating Cancer Mortality Rates by Immigration Status M Yu, National Cancer Institute, Rockville, MD, United States

3H2 Excess Hazard in the Belgian Cancer Population G Silversmit, Belgian Cancer Registry, Brussels, Belgium

3H3 Survival Among Adolescents and Young Adults Using JPSurv and SEER9 Data, 1975-2015 D Lewis, National Cancer Institute, Bethesda, MD, United States

3H4 Bayesian Mapping of Cancer Mortality in Japan: A Small Area Analysis M Hori, National Cancer Center, Chuo-ku, Tokyo, Japan

Day 3

4A1 Monitoring of Incidence and Mortality of Cancers around Fukushima Nuclear Plant Accident Area: Inter-Regional Analysis T Matsuda, National Cancer Registry Center & National Cancer Center, Japan

4A2 Radiation Risk Of Colorectal Cancer by Anatomical Site Among Atomic Bomb Survivors: 1958-2009 H Sugiyama, Radiation Effects Research Foundation, Hiroshima, Japan

4A3 Investigation of a Possible Link between Pollution from Firefighting Foam and Cancer in the Greater Fairbanks Area, Alaska D O’Brien, Alaska Cancer Registry, Anchorage, AK, United States

4A4 Cancer Risk Among Male Florida Firefighters (1981-2014): Evidence from the Florida Firefighter Cancer Registry D Lee, Florida Cancer Data System, Miami, FL, United States

4A5 The Camp Lejeune Cancer Incidence Study: A Retrospective Cohort Study F Bove, Division of Toxicology and Human Health Sciences, ATSDR/CDC Atlanta, GA, United States

4B1 Survival Outcomes in Adolescent Hematologic Cancer Patients in Estonia: Does Place of Treatment Matter? K Paapsi, National Institute for Health Development, Tallinn, Estonia

4B2 Changes in Life Expectation for Diffuse Large B-Cell Lymphoma (DLBCL) Patients, 1985-2014: Results from SEER Data R Dewar, Nova Scotia Health Authority – Cancer Care Program, Halifax, NS, Canada

4B3 Trend in Survival From Leukemia in Children, Adolescents and Young Adults in Osaka, Japan: Is the Age-Related Gap Narrowing? K Nakata, Osaka International Cancer Institute, Osaka, Japan

4C1 Tracking Recurrence in Population-Based Cancer Surveillance: Where to Start? Literally! L Pollack, Centers for Disease Control and Prevention, Atlanta, GA, United States

4C2 Defining Cancer Recurrence in a Population-Based Cancer Surveillance Study T Thompson, Centers for Disease Control and Prevention, Atlanta, GA, United States

4C3 Capturing Cancer Recurrences Using Utah Cancer Registry Data C Bateman, Utah Cancer Registry, Salt Lake City, UT, United States

4C4 Predicting Recurrence or Second Breast Cancer from Linked Registry-Claims Data to Augment SEER: The ReCAPSE Project R Etzioni, Fred Hutchinson, Cancer Research Center, Seattle, WA, United States

4D1 Opportunities to Improve Place of Birth, Race, and Ethnicity with Electronic Birth Certificate Linkage V Otto, Utah Cancer Registry, Salt Lake City, UT, United States

4D2 Furthering the Understanding of the Burden of Cancer among the American Indian and Alaska Native Population in Maine: Assessing the Impact of Case Identification through IHS Linkage and Differences Due to Case and Regional Inclusion Criteria D Yob, Maine Cancer Registry, Augusta, ME, United States

4D3 Feasibility of Using A Patient Portal Distributed by the Statewide Cancer Registry to Collect Patient Generated Health Data (PGHD) M Charlton, State Health Registry of Iowa, Iowa City, IA, United States

4D4 Innovative Electronic Data Capture to Collect Screening and Diagnostic Follow-Up for Women with Breast or Cervical Cancer C Sweeney, Utah Cancer Registry, Salt Lake City, UT, United States

4E1 Cancer in Young People in Canada: Broadening the Research and Surveillance Potential by Linking to Other Administrative Databases S Bryan, Health Data Integration – Statistics Canada, Ottawa, ON, Canada

4E2 Early- and Late-Age Onset Colorectal Cancer in Kentucky: Using Health Administrative Claims-Linked Cancer Registry Data to Better Understand Risk Factors and Comorbidities J Townsend, Centers for Disease Control and Prevention, Chamblee, GA, United States

4E3 Investigating the Effects Of Socioeconomic Factors on Cancer Treatment Patterns and Outcomes In Canada Using Individual-Level Linked National Data A Smith, Canadian Partnership Against Cancer, Toronto, ON, Canada

4E4 Lung Cancer Incidence and Risk Factors in Never-Smoking Asian American, Native Hawaiian, and Pacific Islander Women: The Development of a Multilevel Integrated Dataset of Electronic Health Record, Cancer Registry, and Environmental Data M DeRouen, Department of Epidemiology and Biostatistics, UCSF, San Francisco, CA, United States

4F1 Estimating the Number of People in Italy Living After a Childhood Cancer Using the Software COMPREV A Gigli, National Research Council, Institute for Research on Population and Social Policies, Roma, Italy

4F2 Using NAACCR CiNA Data to Estimate Blood Cancer Prevalence in the United States Using More Complete Geographic Coverage and Provide Local Estimates C Johnson, Cancer Data Registry of Idaho, Boise, ID, United States

4F3 Lifetime Risk of Developing Cancer Among Alaska Native People S Nash, SEER Alaska Native Tumor Registry, Anchorage, AK, United States

4G1 Neighborhood Archetypes for Understanding Disparities in Prostate Cancer Mortality M DeRouen, Department of Epidemiology and Biostatistics, UCSF, San Francisco, CA, United States

4G2 Socio-Economic Position and Comorbidity Prevalence Among Colon, Rectum, Lung and Hodgkin Lymphoma Cancer Patients in England: A Population-Based Study Using Cancer Registry Data and Electronic Health Records H Fowler, London School of Hygiene and Tropical Medicine, London, United Kingdom

4G3 The Social Gradient of Cancer Incidence in New York State F Boscoe, Portland, ME, United States

4G5 Adding Value to Registries through Geospatial Big Data Fusion T Haithcoat, University of Missouri, Columbia, MO, United States

4H1 Coming to America: Cancer Trends among Filipinos in Manila and Los Angeles A Sipin-Baliwas, Los Angeles Cancer Surveillance Program -USC, Los Angeles, CA, United States

4H2 Liver Cancer Statistics in China, 2015: An Updated Estimate Based on 368 Population-Based Cancer Registries L An, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

4H3 Cancer Registration and Its Role in Cancer Prevention and Control in China W Wei, National Cancer Center, Beijing, China

Day 4

5A1 Trends of Cancer Observed in a Premier Institute in Mumbai, India During Last Three Decades G Balasubramaniam, Tata Memorial Centre, Navi Mumbai, Maharashtra, India

5A2 Patterns of Cancer Incidence and Mortality Rates and Trends in China S Zhang, National Cancer Center, China

5A3 The Rising Incidence of Testicular Cancer Among Young Men in Canada, Data from 1971-2015 D Brenner, University of Calgary, Calgary, AB, Canada

5A4 Trends in Cancer Incidence in the Republic of Mauritius, 1991-2015 M Koon Sun Pat, Faculty of Science, University of Mauritius, Reduit, Mauritius, Tombeau Bay, PA, Mauritius

5C1 Therapy-Related Acute Myeloid Leukemia Following Treatment for Cancer in Childhood: A Population-Based Registry Study J Aitken, Cancer Council Queensland, Queensland, Australia

5C2 Quantifying the Risk of Second Primary Melanoma in California, 2000-2015 E Stewart, Cancer Registry of Greater California, Sacramento, CA, United States

5C3 How to Interpret the Geographical Variations in the Incidence of Bladder Tumours in Europe C Martos Jiménez, European Commission – DG Joint Research Centre, Brussels, Belgium

5C4 Thyroid Cancer Epidemiology in the Northeast of São Paulo State, Brazil: A Population-Based Time Trends Study A Mafra, Barretos Cancer Hospital, Barretos, São Paulo, Brazil

5D1 Wilms Tumor: The Value of Abstract Text Fields for Determining Prognosis Based on Histology M Whiteside, Tennessee Cancer Registry, Nashville, TN, United States

5D2 Utilization of Microsatellite Instability Testing and Associated Factors Among Colorectal Cancer Patients X Wu, Louisiana Tumor Registry, New Orleans, LA, United States

5D3 Evaluating the Utilization of Lower Anogenital Squamous Terminology (LAST) Two-tiered Classification for Pre-invasive Cervical Cancer and Its Impact on Reporting in a Population-Based Cancer Registry MC Hsieh, Louisiana Tumor Registry, New Orleans, LA, United States

5D4 Quality Review of Pancreas Surgery Codes P Nicolin, Metropolitan Detroit Cancer Surveillance System, Detroit, MI, United States

5D5 Completeness of Molecular Testing Information Among Metastatic Colorectal Cancer Patients – A Comparison of Data Sources at an Academic Medical Center, A Kahl, State Health Registry of Iowa, Iowa City, IA, United States

5E1 Medical Chart Review for Screening History Among Women with Invasive Cervical Cancer in Three States: CICC Study, 2013-2016 A Greek, Battelle, Seattle, WA, United States

5E2 Estimating the Efficiency of Three National Cancer Screening Programmes Using the Population-Based Cancer Registry Data in Slovenia V Zadnik, Slovenian Cancer Registry, Institute of Oncology, Ljubljana, Slovenia

5E3 Cancer Registry Collaboration with Cancer Control Program on a Population-Based Survey of Utah Cancer Survivors K Herget, Utah Cancer Registry, Salt Lake City, UT, United States

5E5 Maximizing Research Impacts on Cancer Prevention: An Integrated Knowledge Translation Approach Used by the Canadian Population Attributable Risk of Cancer (ComPARe) Study P De, Ontario Cancer Registry, Toronto, ON, Canada

5G1 A First Look at Cancer Incidence Rates and Trends in Bermuda Over the 10-Year Period 2007-2016 S Quesnel-Crooks, IARC Caribbean Cancer Registry Hub, Port of Spain, Trinidad and Tobago

5G2 Findings of First Population Based Cancer Registry in Nepal R Subedi, Nepal Health Research Council, Kathmandu, Nepal

5G3 Cost of Operating Population-Based Cancer Registries: Results from Four Sub-Saharan African Countries P Edwards, RTI International, Durham, NC, United States

5G5 Costs and Resources Used by Population-Based Cancer Registries in the U.S.-Affiliated Pacific Islands P Edwards, RTI International, Durham, NC, United States

5H1 Surveillance of HPV-associated Oropharyngeal Cancers in South Carolina S Chiodini, South Carolina Central Cancer Registry, Columbia, SC, United States

5H2 Cervical Cancer in Adolescent and Young Adults in California, 2005-2014 F Maguire, California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Health, Institute for Population Health Improvement, Sacramento, CA, United States

5H3 Risk of HPV-related Extra-Cervical Cancers in Women with a Removed Intraepithelial Cervical Lesion S Rosso, Piedmont Cancer Registry,, Turin, Italy

5H4 Monitoring of HPV Genotype Prevalence Ten Years after HPV Vaccine Implementation T Tucker, Kentucky Cancer Registry, Lexington, KY, United States

5H5 Bridging Colorado’s Cancer and Immunization Registries to Improve the Dissemination of a Successful HPV Vaccination Intervention A Mellies, University of Colorado, Aurora, CO, United States

Funding for this web site content was made possible in part by a contract with Federal funds from the National Cancer Institute, National Institutes of Health and Department of Health & Human Services under Contract number 75N91021D00018 / 75N91021F00001. Additionally, funding for this web site content was made possible in part by a cooperative agreement with Federal funds from the Centers for Disease Control and Prevention Cooperative Agreement number 1NU58DP007575. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCI and CDC.

Copyright © 2018 NAACCR, Inc. All Rights Reserved | See NAACCR Partners and Sponsors